Top Story

Bisphosphonates may reduce risk for bone metastases in women with breast cancer

October 27, 2014

Women with breast cancer who used low-dose oral bisphosphonates for postmenopausal osteoporosis demonstrated a reduced risk for bone metastases, according to study results.

“Skeletal metastases develop in up to 70 percent of women who die from breast cancer,” researcher Richard Kremer, MD, director of the Bone and Mineral Unit at McGill University Health Centre and professor with the faculty of medicine at McGill University, said in a press release. “This causes considerable suffering and is life-threatening. Preventing this could translate into saving a significant number of lives.”

In the Journals

Everolimus–exemestane combination failed to significantly extend OS in advanced breast cancer

October 21, 2014
The addition of everolimus to exemestane extended OS in postmenopausal women with HR-positive, HER-2–negative advanced breast cancer, but the difference was not…
Meeting News Coverage

Maintenance therapy with bevacizumab, capecitabine extended survival in HER-2–negative breast cancer

October 17, 2014
Patients with HER-2–negative metastatic breast cancer who underwent maintenance therapy with bevacizumab and capecitabine demonstrated significantly longer PFS and…
figure Meeting News Coverage

Bevacizumab plus second-line chemotherapy extended PFS in HER-2–negative breast cancer

October 16, 2014
The addition of bevacizumab to second-line chemotherapy significantly extended PFS among patients with locally recurrent or metastatic HER-2–negative breast cancer…
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
figure

Nomogram predicted recurrence risk among women who underwent APBI

September 26, 2014
Jessica Wobb, MD, senior resident in radiation oncology at Beaumont Health System in Birmingham, Mich., describes how…
More »
CME
figure

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »

Filter By:

In the Journals

Bisphosphonates may reduce risk for bone metastases in women with breast cancer

October 27, 2014
Women with breast cancer who used low-dose oral bisphosphonates for postmenopausal osteoporosis demonstrated a reduced risk for bone metastases…
In the Journals

Everolimus–exemestane combination failed to significantly extend OS in advanced breast cancer

October 21, 2014
The addition of everolimus to exemestane extended OS in postmenopausal women with HR-positive, HER-2–negative advanced breast cancer, but the…
Meeting News Coverage

Maintenance therapy with bevacizumab, capecitabine extended survival in HER-2–negative breast cancer

October 17, 2014
Patients with HER-2–negative metastatic breast cancer who underwent maintenance therapy with bevacizumab and capecitabine demonstrated…
figure Meeting News Coverage

Bevacizumab plus second-line chemotherapy extended PFS in HER-2–negative breast cancer

October 16, 2014
The addition of bevacizumab to second-line chemotherapy significantly extended PFS among patients with locally recurrent or metastatic…
Meeting News Coverage Perspective

Medicare program improved breast cancer hormonal therapy adherence

October 16, 2014
Women with breast cancer were more likely to adhere to hormonal therapy after surgery regardless of their ethnicity if they received a low-income…
FDA News

FDA grants priority review to palbociclib for advanced breast cancer

October 13, 2014
The FDA granted priority review status to palbociclib for use with letrozole in first-line treatment for postmenopausal women with ER-positive…
In the Journals

Increase in skirt size led to higher risk for postmenopausal breast cancer

October 10, 2014
An increase in skirt size each decade among women aged between their mid-20s and mid-50s appeared to be associated with a 33% elevated risk for…
Institution Notes

Vanderbilt professor receives research award

October 8, 2014
Vandana Abramson, MD, received the Advanced Clinical Research Award in Breast Cancer from ASCO’s Conquer Cancer Foundation. Abramson…
In the Journals

Breast cancer radiotherapy did not induce liver stiffness

October 8, 2014
Radiotherapy was not correlated with liver stiffness or fibrosis among patients with breast cancer, according to study data.Sixty patients with…
figure In the Journals

One-third of cancer patients experienced anxiety, mental health disorders

October 6, 2014
About one in three patients with cancer experienced some level of clinically relevant mental health challenge, such as anxiety, depressive disorders…
More Headlines »